TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31898939

Group type: EXPERIMENTAL
Intervention: Reduced-dose tacrolimus with standard-dose mycophenolate mofetil (MMF)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard-dose tacrolimus with reduced-dose mycophenolate mofetil (MMF)
Number of subjects: 108
Study: 30539929

Group type: EXPERIMENTAL
Intervention: High-fidelity interprofessional simulation educational intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional classroom lesson (Control Group)
Number of subjects: 0
Study: 27151255

Group type: EXPERIMENTAL
Intervention: Eltrombopag (up to 75 mg/day) for 7 or 13 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eltrombopag (up to 75 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eltrombopag (open-label treatment for ≥24 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26700278

Group type: EXPERIMENTAL
Intervention: Tai Chi training (12 weeks, 5 days/week, 60 min/day)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Usual physical activities (control group)
Number of subjects: 170
Study: 22960709

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - social stress induction through exclusion in a virtual ball game and negative feedback
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control Group (CG) - included in the game and received neutral feedback
Number of subjects: 76
Study: 21079428

Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 1670

Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT) with HAART
Number of subjects: 1670
Study: 18434189

Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg/day)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg/day) + Naltrexone (50 mg/day)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg/day) + GHB (75 mg/kg)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg/day) + Naltrexone (50 mg/day) + GHB (75 mg/kg)
Number of subjects: 47
Study: 16520204

Group type: EXPERIMENTAL
Intervention: Intravenous patient-controlled analgesia (PCA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia (PCEA)
Number of subjects: 32
Study: 12660585

Group type: EXPERIMENTAL
Intervention: 1% carteolol alginate once daily
Number of subjects: 151

Group type: COMPARATOR
Intervention: 1% carteolol standard solution twice daily
Number of subjects: 151
Study: 10942100

Group type: EXPERIMENTAL
Intervention: Better understanding of disease
Number of subjects: 214

Group type: COMPARATOR
Intervention: Poor understanding of disease
Number of subjects: 214
Study: 9098601

Group type: EXPERIMENTAL
Intervention: Computer interpretation of ECG analysis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Visual interpretation of ECG analysis
Number of subjects: 120
Study: 8097273

Group type: EXPERIMENTAL
Intervention: Fluconazole (150 mg oral dose, once a week)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 3513516

Group type: EXPERIMENTAL
Intervention: Instant and sustained-release verapamil
Number of subjects: 103

Group type: COMPARATOR
Intervention: Nifedipine (control)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Verapamil (all formulations)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 103
Study: 29809024

Group type: EXPERIMENTAL
Intervention: Work-family intervention
Number of subjects: 0
Study: 29909024

Group type: EXPERIMENTAL
Intervention: Coaching training intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional training
Number of subjects: 22
Study: 26919580

Group type: EXPERIMENTAL
Intervention: SMS‐DWI with respiratory‐triggering (SMS‐RT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: SMS‐DWI with free breathing (SMS‐FB)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard DWI with respiratory‐triggering (STD‐RT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard DWI with free breathing (STD‐FB)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: SMS‐DWI (both breathing schemes)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: SMS‐DWI
Number of subjects: 22
Study: 24813776

Group type: EXPERIMENTAL
Intervention: Inside-out vein graft as a cuff after direct suture (Group B)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Direct suture without vein graft (Group A)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inside-out vein graft as a cuff (Group B)
Number of subjects: 10
Study: 22142458

Group type: EXPERIMENTAL
Intervention: 100 ml vodka (30 g alcohol) with 200 ml orange juice
Number of subjects: 24

Group type: COMPARATOR
Intervention: Only orange juice
Number of subjects: 24
Study: 20489017

Group type: EXPERIMENTAL
Intervention: Microbial genome sequencing
Number of subjects: 178
Study: 18358083

Group type: EXPERIMENTAL
Intervention: moxifloxacin
Number of subjects: 738

Group type: COMPARATOR
Intervention: levofloxacin + ceftriaxone
Number of subjects: 738
Study: 16103605

Group type: EXPERIMENTAL
Intervention: Myrrh (Mirazid)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Praziquantel
Number of subjects: 104

Group type: COMPARATOR
Intervention: Praziquantel (offered to individuals uncured after two myrrh treatments)
Number of subjects: 104
Study: 11941903

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment in women
Number of subjects: 959

Group type: COMPARATOR
Intervention: Antihypertensive treatment in men
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: One drug treatment
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Fixed combination therapy
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Free combination therapy
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: ACE inhibitors/AT‐II antagonists
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 959
Study: 10024093

Group type: EXPERIMENTAL
Intervention: Resistant starch supplements
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional starches
Number of subjects: 24
Study: 8636524

Group type: EXPERIMENTAL
Intervention: 100 mg of liquid 5% lidocaine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 100 mg of 2% lidocaine paste
Number of subjects: 9
Study: 2149050

Group type: EXPERIMENTAL
Intervention: Vancomycin (30 mg/kg/d)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Teicoplanin (6 mg/kg every 12 h on day 1, then daily)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 151

Group type: COMPARATOR
Intervention: Vancomycin and Teicoplanin
Number of subjects: 151
Study: 398661

Group type: EXPERIMENTAL
Intervention: 4 mg domperidone I.V.
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 10 mg domperidone I.V.
Number of subjects: 47
Study: 31923565

Group type: EXPERIMENTAL
Intervention: 10 g kg‐1 Fishwort Powder (FWP)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Fishwort Powder (FWP)
Number of subjects: 320
Study: 31094461

Group type: EXPERIMENTAL
Intervention: Umifenovir (Arbidol) 800 mg/day for 5 days (n=181)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Umifenovir (Arbidol)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Placebo 4 times a day for 5 days (n=178)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 359
Study: 29067426

Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopic surgery (n=237)
Number of subjects: 471

Group type: COMPARATOR
Intervention: Conventional laparoscopic surgery (n=234)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopic surgery (n=235)
Number of subjects: 471

Group type: COMPARATOR
Intervention: Conventional laparoscopic surgery (n=224)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopic surgery
Number of subjects: 471

Group type: COMPARATOR
Intervention: Conventional laparoscopic surgery
Number of subjects: 471
Study: 26757190

Group type: EXPERIMENTAL
Intervention: B vitamins (folic acid, vitamins B6 and B12)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid
Number of subjects: 266
Study: 26118077

Group type: EXPERIMENTAL
Intervention: Homotoxicological medicines (Lymphomyosot, Galium‐Heel®, Traumeel S, Echinacea compositum S, Bronchalis‐Heel®, Mucosa compositum) in addition to standard anti‐inflammatory therapy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard anti‐inflammatory therapy
Number of subjects: 97
Study: 21996132

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine 40 mg (n = 6)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine 60 mg (n = 7)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (n = 3)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine (both doses)
Number of subjects: 13
Study: 19542895

Group type: EXPERIMENTAL
Intervention: 100% oxygen for 15 min
Number of subjects: 30

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 30

Group type: COMPARATOR
Intervention: Baseline muscle sympathetic nerve activity
Number of subjects: 30
Study: 17719273

Group type: EXPERIMENTAL
Intervention: Maximal in-hospital diuretic dose
Number of subjects: 395
Study: 15808387

Group type: EXPERIMENTAL
Intervention: Oxybutynin starting dose of 2.5 mg bd
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Oxybutynin starting dose of 5 mg nocte
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 96
Study: 12150234

Group type: EXPERIMENTAL
Intervention: Studying names of 4 members of a hypothetical group
Number of subjects: 0
Study: 9448164

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily, amoxicillin 500 mg t.i.d., metronidazole 500 mg t.i.d.
Number of subjects: 92

Group type: COMPARATOR
Intervention: Amoxicillin 500 mg t.i.d., metronidazole 500 mg t.i.d.
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Metronidazole-resistant H. pylori strains
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Metronidazole-sensitive H. pylori strains
Number of subjects: 92
Study: 8554951

Group type: EXPERIMENTAL
Intervention: 12 micrograms eformoterol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 24 micrograms eformoterol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2121360

Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg tablets once daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Phosphatidylserine (100 mg capsules twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study: 7381310

Group type: EXPERIMENTAL
Intervention: Peer tutoring sessions with tutors who learned to correct and reinforce students in a nonhostile manner.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peer tutoring sessions participation frequency.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 60
Study: 28799963

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 1427
Study: 27480987

Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fluoride varnish plus fluoride toothpaste
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CPP-ACP plus crème plus fluoride toothpaste
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fluoride varnish and CPP-ACP crème plus fluoride toothpaste
Number of subjects: 45
Study: 25550295

Group type: EXPERIMENTAL
Intervention: Safer sex video intervention
Number of subjects: 1252

Group type: COMPARATOR
Intervention: Standard waiting room experience
Number of subjects: 1252
Study: 22751169

Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor (G-CSF)
Number of subjects: 8
Study: 20035984

Group type: EXPERIMENTAL
Intervention: 200 U BTX‐A initially, with subsequent injections between 100 and 300 U
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dose alteration in BTX‐A
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Repeated injections of BTX‐A
Number of subjects: 34
Study: 18703937

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 2185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2185
Study: 15758796

Group type: EXPERIMENTAL
Intervention: Tolterodine (2 mg daily)
Number of subjects: 711

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 711
Study: 12618254

Group type: EXPERIMENTAL
Intervention: Electric vacuum aspiration
Number of subjects: 84

Group type: COMPARATOR
Intervention: Manual vacuum aspiration
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 84
Study: 10966890

Group type: EXPERIMENTAL
Intervention: Lipid emulsion (10% triacylglycerol emulsion) + heparin (200 U bolus followed by 0.2 U*min(‐)(1)*kg body wt(‐)(1)) for 180 min
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.9% NaCl for 180 min
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lipid emulsion + heparin with propranolol infusion (n = 8)
Number of subjects: 30
Study: 8828369

Group type: EXPERIMENTAL
Intervention: Aprotinin high-dose (300 x 10^4 units)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Aprotinin low-dose (100 x 10^4 units)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Aprotinin administration
Number of subjects: 45
Study: 1325880

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg/day for 3 weeks and then 20 mg/day for 4 weeks (n = 12)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 15

Group type: COMPARATOR
Intervention: Doxazosin 1-8 mg/day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combined treatment with doxazosin and enalapril
Number of subjects: 15
Study: 6742335

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and Jaboulay pyloroplasty (Group 1)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy and Jaboulay pyloroplasty (Group 2)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Parietal cell vagotomy without drainage (Group 3)
Number of subjects: 67
Study: 30851536

Group type: EXPERIMENTAL
Intervention: Premature Infant Oral Motor Intervention (PIOMI) administered over 10 days.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Routine nursing services (Control group).
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Weight measurements over time for intervention group.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Weight measurements over time for control group.
Number of subjects: 30
Study: 29214740

Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (400 μg) plus intravitreal antibiotics (0.2 mg vancomycin and 0.05 mg gentamicin)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo plus intravitreal antibiotics (0.2 mg vancomycin and 0.05 mg gentamicin)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (400 μg) plus intravitreal antibiotics
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo plus intravitreal antibiotics
Number of subjects: 167
Study: 26768146

Group type: EXPERIMENTAL
Intervention: Drug Eluting Balloon (DCB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Plain Old Balloon Angioplasty (POBA)
Number of subjects: 64
Study: 27041697

Group type: EXPERIMENTAL
Intervention: Presurgical orthodontic treatment before secondary alveolar bone grafting (SABG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional SABG alone (without presurgical orthodontic treatment)
Number of subjects: 24
Study: 22744733

Group type: EXPERIMENTAL
Intervention: Short message service (SMS) questionnaire, n = 171
Number of subjects: 564

Group type: COMPARATOR
Intervention: Web questionnaire, n = 182
Number of subjects: 564

Group type: COMPARATOR
Intervention: Paper questionnaire, n = 211
Number of subjects: 564
Study: 20405117

Group type: EXPERIMENTAL
Intervention: Combination of 80 ppm inhaled nitric oxide (iNO) and 100% oxygen (O(2))
Number of subjects: 0

Group type: COMPARATOR
Intervention: O(2) alone
Number of subjects: 0
Study: 18315511

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture (scalp AP) sessions twice weekly for 9 months in group B, alongside language therapy (LT).
Number of subjects: 20

Group type: COMPARATOR
Intervention: Language therapy (LT) twice weekly for 9 months in both groups.
Number of subjects: 20
Study: 15999468

Group type: EXPERIMENTAL
Intervention: Leukoreduced blood and/or blood product transfusion (BBPT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (unfiltered BBPT)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Leukoreduced BBPT
Number of subjects: 69
Study: 12423324

Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg in the evening)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phototherapy (2500 Lux for 1 h in the morning)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10066203

Group type: EXPERIMENTAL
Intervention: Higher dose rivastigmine (6-12 mg/day)
Number of subjects: 725

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: Lower dose rivastigmine (1-4 mg/day)
Number of subjects: 725
Study: 7783097

Group type: EXPERIMENTAL
Intervention: Omron HEM403C
Number of subjects: 212
Study: 1914054

Group type: EXPERIMENTAL
Intervention: Low-dose alfentanil (35.1 micrograms.kg‐1 then continuous infusion of 16.2 micrograms.kg‐1.hr‐1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Mid-dose alfentanil (70.2 micrograms.kg‐1 then continuous infusion of 32.4 micrograms.kg‐1.hr‐1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High-dose alfentanil (105.3 micrograms.kg‐1 then continuous infusion of 48.6 micrograms.kg‐1.hr‐1)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Fentanyl (8.3 micrograms.kg‐1 then continuous infusion of 1.6 micrograms.kg‐1.hr‐1)
Number of subjects: 33
Study: 6307933

Group type: EXPERIMENTAL
Intervention: Pectin (36 g/d for 3 weeks)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Brown and wholemeal breads (3 weeks each)
Number of subjects: 11

Group type: COMPARATOR
Intervention: White bread (3 weeks)
Number of subjects: 11
Study: 31822548

Group type: COMPARATOR
Intervention: Cemented hemiarthroplasty
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite coated uncemented hemiarthroplasty
Number of subjects: 1128
Study: 29298102

Group type: EXPERIMENTAL
Intervention: Deer Bone Extract (DBE) 550 mg/day for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 26792619

Group type: EXPERIMENTAL
Intervention: Aquatic therapy (pool exercises) starting 6 days after surgery
Number of subjects: 827

Group type: EXPERIMENTAL
Intervention: Ergometer cycling starting 2 weeks after surgery
Number of subjects: 827

Group type: COMPARATOR
Intervention: Nonergometer group (control)
Number of subjects: 827

Group type: EXPERIMENTAL
Intervention: Timing of aquatic therapy
Number of subjects: 827
Study: 25107542

Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (400 micrograms)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study: 21841518

Group type: EXPERIMENTAL
Intervention: Combination paste (morphine + methylprednisolone)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Steroid paste (methylprednisolone alone)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Morphine paste (morphine alone)
Number of subjects: 201
Study: 19260867

Group type: EXPERIMENTAL
Intervention: Insulin resistance
Number of subjects: 3441

Group type: EXPERIMENTAL
Intervention: Obesity measures (BMI, waist circumference, waist-to-hip ratio)
Number of subjects: 3441
Study: 21035949

Group type: EXPERIMENTAL
Intervention: Meditation retreat participants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 30
Study: 16049250

Group type: EXPERIMENTAL
Intervention: Arthroflow device and LMWH
Number of subjects: 227

Group type: COMPARATOR
Intervention: LMWH only
Number of subjects: 227
Study: 12081672

Group type: EXPERIMENTAL
Intervention: Microprocessor-controlled local anesthesia (Wand)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Traditional injection technique
Number of subjects: 101
Study: 10638393

Group type: EXPERIMENTAL
Intervention: Intravenous N-acetylcysteine infusion (3.4-4.6 mg/kg/h for 24 hours in study I; 0.3-1.3 mg/kg/h for 6 days in study II)
Number of subjects: 16
Study: 7499080

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (50,000 IU for neonates, 100,000 IU for 1-11 month-olds, 200,000 IU for 1-4 year-olds)
Number of subjects: 4766

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4766

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 4766
Study: 1911318

Group type: EXPERIMENTAL
Intervention: Oral indomethacin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 7022295

Group type: EXPERIMENTAL
Intervention: Low-dose CMF (cyclophosphamide, methotrexate, and 5-fluorouracil)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard-dose CMF (cyclophosphamide, methotrexate, and 5-fluorouracil)
Number of subjects: 104
Study: 29454763

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 894

Group type: COMPARATOR
Intervention: Biolimus-eluting stent (BES)
Number of subjects: 894

Group type: EXPERIMENTAL
Intervention: OCT-guided implantation
Number of subjects: 894

Group type: COMPARATOR
Intervention: Angiography-guided implantation
Number of subjects: 894

Group type: EXPERIMENTAL
Intervention: 3-month DAPT
Number of subjects: 894

Group type: COMPARATOR
Intervention: 12-month DAPT
Number of subjects: 894
Study: 27443226

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) inflammasome proteins (NLRP1, ASC, caspase‐1) in SAH patients
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) inflammasome proteins in SAH patients with cerebral edema
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) inflammasome proteins in SAH patients with acute hydrocephalus
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High level of NLRP1 in SAH patients
Number of subjects: 34
Study: 24026563

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87